Our recent linkage study of urethane-induced pulmonary adenomas in SMXA RI strains of mouse revealed two host resistance genes, Par1 (chromosome 11) and Par3 (chromosome 12). The map positions of Par1 and Par3 correspond to human 17q11-23 and 14q11-24, based on synteny between mouse and human. In this study, we examined the loss of heterozygosity (LOH) in these two homologous human chromosomal regions in 30 primary lung adenocarcinoma samples with matched normal DNA. Using 15 highly polymorphic markers, two commonly deleted regions were identi®ed on human chromosomes 14 and 17, respectively. At 17q21, nine (53%) of 17 informative tumors showed LOH between D17S588 and D17S518. On the other hand, at 14q11-12, seven (32%) of 22 informative tumors showed LOH at loci between D14S261 and D14S80. Subsequently, we examined 25 squamous cell carcinomas (SQ) and 24 small cell carcinomas (SCC). At 14q11-12, six (38%) of 16 informative SQ and ®ve (42%) of 12 informative SCC showed LOH. In contrast, at 17q11-23, one (7%) of 15 informative SQ and two (14%) of 14 SCC showed LOH. Therefore, the gene on 17q seemed to aect selectively adenocarcinomas, whereas the other gene on 14q, all three types of lung carcinomas. These observations indicate that a comparative genetic analysis provides a promising approach to survey genes involved in multifactorial process of human lung carcinogenesis.
Introduction
Lung cancer is one of most frequent malignancies in industrialized countries. Lung cancer develops through a multistep process in which genetic alterations are accumulated to promote tumorigenesis. Inactivation of tumor suppressor genes plays an important role in this process (Carbone et al., 1992) . Loss of heterozygosity (LOH) is a frequent observation in such tumors. In human lung cancers, LOHs are found on chromosomes 1q, 2q, 3p, 5q, 8q, 9p, 13q, 11p, and 17p and localizations of tumor suppressor genes have been con®rmed or suggested (Tsuchiya et al., 1992) . Urethane-induced pulmonary adenoma (PA) in mice is an excellent model of human lung adenocarcinoma since both tumors share a number of morphological and molecular biological properties (Malkinson et al., 1992) . Mutations in kras2 in mouse PA are as prevalent as in human lung cancers and its allelotype is the primary determinant of disease susceptibility (Dragani et al., 1995) . The involvement of multiple host genes in lung carcinogenesis has been studied extensively in mouse models (Festing et al., 1994) . Recently, we reported two autosomal dominant resistance loci to urethane-induced PA in the SMXA recombinant inbred strain of mice, Par1 and Par3 (Abujiang et al., 1997) . From the synteny map, the regions of Par1 and Par3 are homologous to human 17q11-23 and 14q11-24, respectively. Here, we analysed human lung adenocarcinoma for LOH in homologous regions and found two minimally deleted regions. Subsequent examination of squamous cell carcinomas (SQ) and small cell carcinomas (SCC) for LOH in these regions revealed that 17q contained a gene aecting selectively adenocarcinomas and 14q, another gene aecting all three histological types of lung cancers.
Results
Most of urethane-induced lung tumors in mice are adenomas in histology. Considering the possibility that the function of the Par1 or Par3 homolog may be somehow selective to target cells of tumorigenesis, we ®rst selected 30 primary lung adenocarcinomas and examined their genotypes at 15 highly polymorphic microsatellite marker loci distributed in 14q11-23 and 17q11-24 regions. Figure 1 lists the marker loci in descending order from centromere to telomere, and shows their patterns and frequencies of LOH in the adenocarcinomas examined. Two minimal regions of deletion were identi®ed by this analysis. The ®rst region was bounded by D14S261 proximally and by D14S80 distally. These marker loci have been cytogenetically mapped to chromosome 14q11 and 14q21, respectively. The second region was bounded by D17S588 proximally and by D17S518 distally, and these marker loci have been cytogenetically mapped to chromosome 17q21 and 17q23, respectively. LOH was observed most frequently at D17S588 and D14S261. Nine (53%) of 17 informative tumors showed LOH at marker locus D17S588. At locus D14S261, seven (32%) of 22 informative tumors showed LOH. Representative cases of LOH analysis at several marker loci are shown in Figure 2 . At D14S261, the patient 9 did not show LOH, since DNAs from both tumor and non-tumor tissue retained two alleles, whereas the patient 22 showed LOH as one allele was missing in the tumor DNA. Similar LOH was observed in the patients 3 and 10 at D17S588 and D17S855, respectively.
To examine whether LOHs in these regions are speci®c to adenocarcinomas or observed also in other types of lung cancers, we further studied 25 cases of SQ and 24 cases of SCC. Figure 3A ,B schematically shows the patterns of LOH and their frequencies in these tumors. Comparing with lung adenocarcinomas, LOHs at 17q21 were less frequent in SQ and SCC as summarized in Table 1 . Therefore, the LOH on 17q seemed to be associated with adenocarcinomas (P50.05). On the other hand, LOHs at 14q11-12 in SQ (30%) and SCC (42%) were as frequent as in adenocarcinomas (32%) ( Table 1) , indicating the LOHs on 14q were prevalent to all types of lung cancers.
To further characterize the role of the putative tumor suppressor gene in this region in lung cancer, we examined the possible associations of LOHs on 14q and 17q with clinicopathological parameters including sex, degree of dierentiation, smoking history, TNM stage and lymph node metastasis. However, no positive association was found (Table 2) .
Discussion
Comparative genetic analysis is one of promising approaches to characterize complicated diseases in human. It is increasingly evident that there is an extensive syntenic conservation of genomic organization among species, and comparative genetic maps have been used to predict the locations of genes in other species. The present study aimed to extend the genetic information obtained in chemical-induced lung tumors in the mouse to survey genetic changes in human lung cancers. Analysis of 79 cases of human lung cancer revealed frequent LOHs in two distinct chromosomal regions. One of locus at 17q21 seem to play signi®cant role in lung adenocarcinomas. On the other hand, another locus at 14q11-12 seemed to play signi®cant role in all types of lung cancers. These results suggest the existence of putative tumor suppressor genes in these regions. LOHs in 17q21 have been reported in a variety of malignancies including breast (Cropp et al., 1993) , ovary (Wertheim et al., 1996) and prostate cancers (Gao et (Sato et al., 1993) . Recent positional cloning of the BRCA1 from that region and its mutation screening support that the BRCA1 is responsible for inherited breast (Jandrig et al., 1996) and ovarian cancer (Merajver et al., 1995) . It would be interesting to screen for BRCA1 mutations in tumor samples which demonstrate LOH at the BRCA1 locus. This will provide evidence to either prove or disprove the hypothesis that the BRCA1 gene is indeed involved in lung cancer. Fong et al. (1995) also showed 45% of LOH in lung adenocarcinomas and 29% of LOH in SQ overall 17q. They used Southern blot analysis of RFLPs (Fong et al., 1995) , so that it is dicult to compare their results with ours. Whether or not these observations direct the deletion of the same critical locus will require further study. Cancers of colorectal tract (Chang et al., 1995) , kidney (Thrash-Bingham et al., 1995) , endometrium (Chang et al., 1995) , bladder (Chang et al., 1995) , ovary (Cliby et al., 1993b) and neuroblastoma (Takayama et al., 1992) are solid cancers associated with a signi®cant degree of 14q LOH. The proximal end of the region de®ned in our study overlaps with the region de®ned in the ovarian carcinoma study. Assuming that the deletion observed at 14q11-12 in bladder, ovarian and lung cancers are driven by the same gene, the identi®cation and characterization of this tumor suppressor locus would be expected to represent a substantial advance in the ®eld of cancer molecular genetics. Although these regions are not small enough to plausibly indicate a positional cloning eort, it is possible to narrow down the minimal regions of deletion through the identi®cation of additional microsatellite markers to saturate these regions and to perform LOH analysis of a larger series of tumors with them. We concentrated on lung cancers, because the primary aim of this study was to seek common genetic events among species in carcinogenesis of homologous type tumors.
In murine urethane-induced PA, four resistance genes (Par1-4) have been identi®ed (Abujiang et al., 1997; Manenti et al., 1997) . Par2 is mapped on chromosome 18 close to the putative tumor suppressor gene DCC. Although we did not examine the Par2 homologous region, frequent LOH of DCC in human lung cancers has been reported (Zhang et al., 1995) . Par4 was recently mapped to chromosome 6 (Manenti et al., 1997), but its syntenic region has not been examined. To date, therefore, 3 of 4 mouse PA resistance genes have syntenic human chromosomal regions bearing hot spots for LOH in lung adenocarcinomas. These observations suggest the presence of shared genetic steps in lung carcinogenesis across species.
Materials and methods
Samples and DNA extraction.
Lung tumors and corresponding nontumorous tissue were obtained at surgery from 79 patients. Types of tumors were con®rmed histologically. Tissues were frozen immediately and stored at 7808C. DNA was extracted from frozen tissue according to the methods described previously (Abujiang et al., 1996) .
Fluorescent microsatellite analysis.
We chose 15 microsatellite markers along 14q and 17q arms. Map positions of these loci were based on the Human Genetic Map (Cold Spring Harbor Laboratory Press 1993, Stephen J O'Brien) and CEPH/CHLC databases. The oligonucleotides were labeled with 6-FAM¯uorescent dye, and the TAMRA dye was reserved for the size standard. PCR for¯uorescent markers was carried out in a volume of 9 ml and included 106PCR buer, 50 ng of DNA, 250 mM of each dNTP, 0.5 units of Dynazyme Taq polymerase and 10 pmol of each primer. The thermal pro®le was as follows: 948C for 2 min; 35 cycles of 948C for 30 s, 538C for 40 s, and 728C for 1 min; and a ®nal extension of 728C for 10 min. One ml of products were added to 2.5 ml of formamide, 0.5 ml of blue dextran and 0.5 ml of TAMRA 500 size standard (Applied Biosystems), loaded on 4% polyacrylamide 6-M urea gels, and run for 2 h in a 377A Automated Sequencer (Applied Biosystems). The data were collected automatically and analysed using GeneScan software (Applied Biosystems); ®nally, the Genotyper software (Applied Biosystems) and Exel software were used for allele scoring and assessment of LOH. In the case of constitutional heterozygotes, two alleles are detected in normal tissue, and if one is absent in the tumor the result is LOH. The program checks for LOH by calculating the ratio of the constitutional alleles (Canxian et al., 1996) .
Statistical analysis.
The X 2 test was performed to compare LOH frequencies in respect of histopathological type, stage, and grade. P50.05 was considered to indicate statistical signi®cance.
Abbreviations
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